Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30

Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30

$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

Cryo-Cell International price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cryo-Cell International's price to sales ratio was 1.3× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 0.8× to 3.4×, with a median of 1.4×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	1.3×	+0.5
2025	Dec 31, 2025	0.9×	−1.0
2024	Dec 31, 2024	1.9×	+0.4
2023	Dec 29, 2023	1.5×	+0.3
2022	Dec 30, 2022	1.2×	−2.2
2021	Dec 31, 2021	3.4×	+1.6
2020	Dec 31, 2020	1.8×	+0.1
2019	Dec 31, 2019	1.7×	−0.4
2018	Dec 31, 2018	2.2×	−0.6
2017	Dec 29, 2017	2.8×	+1.4
2016	Dec 30, 2016	1.4×	−0.1
2015	Dec 31, 2015	1.4×	+0.2
2014	Dec 31, 2014	1.2×	+0.2
2013	Dec 31, 2013	1.0×	−0.3
2012	Dec 31, 2012	1.3×	+0.0
2011	Dec 30, 2011	1.3×	–

Where these numbers come from

Parsed from the XBRL in Cryo-Cell International's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing